Journal for ImmunoTherapy of Cancer (Nov 2023)
739 Emerging proteomic and safety analysis of blood from solid tumor patients receiving TILT-123 (Ad5/3-E2F-d24-hTNFa-IRES-hIL2) monotherapy in TUNIMO phase 1 clinical trial
- Tuomo Alanko,
- Akseli Hemminki,
- Víctor Cervera-Carrascón,
- João Santos,
- Riikka Havunen,
- Juha Kononen,
- Jorma Sormunen,
- Katriina Peltola,
- Riitta Korpisaari,
- Marjut Jaakkola,
- Suvi Sorsa,
- Santeri A Pakola,
- James Clubb,
- Elise Jirovec,
- Dafne CA Quixabeira,
- Tatiana Kudling,
- Lyna Haybout,
- Claudia Kistler
Affiliations
- Tuomo Alanko
- 4Docrates Cancer Center, Helsinki, Finland
- Akseli Hemminki
- 2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- Víctor Cervera-Carrascón
- 1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- João Santos
- 1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- Riikka Havunen
- 1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- Juha Kononen
- 4Docrates Cancer Center, Helsinki, Finland
- Jorma Sormunen
- 4Docrates Cancer Center, Helsinki, Finland
- Katriina Peltola
- 3Comprehensive Cancer Centre, Helsinki, Finland
- Riitta Korpisaari
- 4Docrates Cancer Center, Helsinki, Finland
- Marjut Jaakkola
- 4Docrates Cancer Center, Helsinki, Finland
- Suvi Sorsa
- 2TILT Biotherapeutics Ltd, Helsinki, Finland
- Santeri A Pakola
- 2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- James Clubb
- 3TILT Biotherapeutics, Helsinki, Finland
- Elise Jirovec
- 2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- Dafne CA Quixabeira
- 1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- Tatiana Kudling
- 2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- Lyna Haybout
- 2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
- Claudia Kistler
- 2TILT Biotherapeutics Ltd, Helsinki, Finland
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0739
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
